Cargando…
Assessment of the pharmacokinetics, removal rate of hemodialysis, and safety of lactulose in hemodialysis patients
Lactulose is often used to treat hepatic encephalopathy or constipation, and also exhibits benefits to chronic renal insufficiency due to reduce nitrogen-related products in serum. The present study investigated the pharmacokinetics of lactulose, its removal rate through dialysis, and safety by admi...
Autores principales: | Lin, Cheng-Jui, Pan, Chi-Feng, Ju, Sy-Yeuan, Tzeng, Hsuan-Kai, Chen, Shen-Wei, Syu, Jhu-Ting, Wu, Chih-Jen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taiwan Food and Drug Administration
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9337276/ https://www.ncbi.nlm.nih.gov/pubmed/28911627 http://dx.doi.org/10.1016/j.jfda.2016.05.007 |
Ejemplares similares
-
Corrigendum to “Assessment of the pharmacokinetics, removal rate of hemodialysis, and safety of lactulose in hemodialysis patients” [J Food Drug Anal 24 (2016) 876–880]
por: Lin, Cheng-Jui, et al.
Publicado: (2017) -
Serum p-cresyl sulfate predicts cardiovascular disease and mortality in elderly hemodialysis patients
por: Lin, Cheng-Jui, et al.
Publicado: (2013) -
Dataset supporting blood pressure prediction for the management of chronic hemodialysis
por: Lin, Cheng-Jui, et al.
Publicado: (2019) -
Heart Rate Variability Change Before and After Hemodialysis is Associated with Overall and Cardiovascular Mortality in Hemodialysis
por: Chen, Szu-Chia, et al.
Publicado: (2016) -
Effective Removal of Dabigatran by Idarucizumab or Hemodialysis: A Physiologically Based Pharmacokinetic Modeling Analysis
por: Fuhr, Laura Maria, et al.
Publicado: (2020)